TIOMA THERAPEUTICS
Formerly Known as Vasculox. Tioma is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. The company's functionally diverse antibodies represent a new class of checkpoint inhibitors that harness both the adaptive and innate immune responses.
TIOMA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2006-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.tiomatherapeutics.com
Total Employee:
101+
Status:
Closed
Contact:
(314)932-4032
Email Addresses:
[email protected]
Total Funding:
95.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx Euro PHP Pound Sterling Japanese Yen Baidu Analytics Baidu Maps
Current Advisors List
Current Employees Featured
Founder
Investors List
Cultivation Capital
Cultivation Capital investment in Series A - Tioma Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Tioma Therapeutics
RiverVest
RiverVest investment in Series A - Tioma Therapeutics
SR One
SR One investment in Series A - Tioma Therapeutics
Novo Ventures
Novo Ventures investment in Series A - Tioma Therapeutics
Cultivation Capital
Cultivation Capital investment in Venture Round - Tioma Therapeutics
Official Site Inspections
http://www.tiomatherapeutics.com
Unable to get host informations!!!
